Bioavailability of Citrus Polymethoxylated Flavones and Their Biological Role in Metabolic Syndrome and Hyperlipidemia

QR Code

Bioavailability of Citrus Polymethoxylated Flavones and Their Biological Role in Metabolic Syndrome and Hyperlipidemia

None

Saved in:

Bibliographic Details
Main Authors:	Evans, Malkanthi, Sharma, Prachi, Guthrie, Najla
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/35687
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Accumulation and change rules of polymethoxylated flavones in different tissues of mandarin
by: WANG Tong, et al.
Published: (2021-12-01)

CHEMICAL STUDY OF FLAVONS AND FLAVONOLS COMPOSITION IN PROPOLIS
by: E. V. Lupina, et al.
Published: (2018-07-01)

Metabolism and Bioavailability of Olive Oil Polyphenols
by: Gómez-Romero, María, et al.
Published: (2012)

Postprandial hyperlipidemia as a coronary atherosclerosis factor in patients with metabolic syndrome; corrective potential of rosuvastatin therapy
by: T. V. Krovyakova, et al.
Published: (1970-01-01)

Potential Modulation of Phytochemical Bioavailability by Furanocoumarins from Citrus × paradisi
by: Luca Bolognini
Published: (2025-06-01)

Validating the antiseizure effects of vitexin and related flavone glycosides in zebrafish
by: Audrey Breckenridge, et al.
Published: (2025-06-01)

Secondary hyperlipidemias: etiology and pathogenesis
by: A. I. Ershova, et al.
Published: (2019-06-01)

The era of targeted therapy for hyperlipidemia
by: U. V. Chubykina, et al.
Published: (2024-10-01)

Hyperlipidemia and atherosclerosis: experimental models
by: K. I. Davletova, et al.
Published: (2025-07-01)

Oral Absorption, Intestinal Metabolism and Human Oral Bioavailability
by: El-Kattan, Ayman, et al.
Published: (2012)

Hyperlipidemia and gut microbiota: the role of prebiotics, probiotics, statins and fibrates
by: I. N. Grigor’eva, et al.
Published: (2025-07-01)

Bioavailability of Phytochemicals
by: Epriliati, Indah, et al.
Published: (2012)

Research Progress on Digestive Behavior and Release Characteristics of Protein-Flavone Delivery System
by: Hao MA, et al.
Published: (2025-07-01)

Biochemical effect of curcumin on hyperlipidemia induced in rats
by: Omayma A.R.,, et al.
Published: (2016-06-01)

Click on Click: Click-Flavone Glycosides Encapsulated in Click-Functionalised Polymersomes for Glioblastoma Therapy
by: Nuno M. Saraiva, et al.
Published: (2025-06-01)

Nutritional bioavailability of zinc
Published: (1983)

Nutritional bioavailability of iron
Published: (1982)

Advancements in curcuminoid formulations: An update on bioavailability enhancement strategies curcuminoid bioavailability and formulations
by: Darmonkow Alexander, et al.
Published: (2025-07-01)

EFFICIENCY AND SAFETY ASSESSMENT OF GENERIC ATORVASTATINE IN PATIENTS WITH HYPERLIPIDEMIA
by: J. E. Semyonova, et al.
Published: (2015-12-01)

Oral Bioavailability and Disposition of Phytochemicals
by: Li, Yan, et al.
Published: (2011)

Factors, effecting on drug bioavailability
by: P. . Bochkov, et al.
Published: (2020-04-01)

Soil nutrient bioavailability a mechanistic approach
by: Barber, Stanley A.
Published: (1984)

Liposomal Nanoparticle Delivery of Ginkgo Flavone Glycosides Enhances SIRT1 Activation and Improves Diabetic Cardiomyopathy
by: Gao W, et al.
Published: (2025-06-01)

Familial combined hyperlipidemia: current status of the problem (literature review)
by: O. V. Timoshchenko, et al.
Published: (2024-10-01)

Osteonecrosis of shoulder and femur in a patient with hyperlipidemia type FV
by: T V Kolesnik, et al.
Published: (2003-04-01)

EFFECTS OF LUDARTIN AND LEUKOMISIN ON THE ACUTE HYPERLIPIDEMIA MODEL INDUCED BY ETHANOL
by: A. V. Ratkin, et al.
Published: (2015-08-01)

EFFECTS OF GROSSHEMIN AND GROSSMISIN ON THE ACUTE HYPERLIPIDEMIA MODEL INDUCED BY ETHANOL
by: A. V. Ratkin, et al.
Published: (2014-02-01)

HYPOLIPIDEMIC EFFECT LEUCOMISINE MODEL OF ACUTE HYPERLIPIDEMIA INDUCED BY ETHANOL
by: E. A. Rodnova, et al.
Published: (2013-02-01)

FORMULATION STRATEGIES FOR ENHANCED TOPICAL BIOAVAILABILITY
by: W. Small
Published: (2019-01-01)

BIOAVAILABILITY OF CURCUMIN AND METHODS OF ITS ENHANCING
by: N. L. Soloveva, et al.
Published: (2019-01-01)

Pharmacokinetic (Bioavailability) Studies of Magnesium Preparations
by: N. N. Eremenko, et al.
Published: (2023-07-01)

Biological and Biosimilar Medicines in Contemporary Pharmacotherapy for Metabolic Syndrome
by: Wiktoria Górecka, et al.
Published: (2025-06-01)

Germinated brown rice relieves hyperlipidemia by alleviating gut microbiota dysbiosis
by: Chuan-ying REN, et al.
Published: (2023-03-01)

Dyslipidemia: Genetics and Role in the Metabolic Syndrome
by: Nock, Nora L., et al.
Published: (2012)

DYSLIPIDEMIA ROLE IN THE DEVELOPMENT OF METABOLIC SYNDROME
by: M. V. Antonyuk, et al.
Published: (2011-10-01)

Comparative Analysis of Anti-Inflammatory Flavones in <i>Chrysanthemum indicum</i> Capitula Using Primary Cultured Rat Hepatocytes
by: Keita Minamisaka, et al.
Published: (2025-07-01)

Double cholesterol inhibition — a new approach to effective control of hyperlipidemia and atherosclerosis
by: A. V. Susekov, et al.
Published: (2009-12-01)

POLOXAMER 407-INDUCED CHRONIC HYPERLIPIDEMIA IS NOT ASSOCIATED WITH DISORDERS OF BLOOD GLUCOSE LEVELS
by: P. Dzhelebov, et al.
Published: (2025-03-01)

Mechanisms of Microctis Folium in Hyperlipidemia: Integrating Serum Pharmacochemistry, Network Pharmacology, and Transcriptomics
by: Xiao G, et al.
Published: (2025-07-01)

A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC SIMVASTATIN IN PATIENTS WITH HYPERLIPIDEMIA
by: V. P. Voronina, et al.
Published: (2016-01-01)